Literature DB >> 9915735

Fortnightly review: anticoagulation in heart disease.

S M Hardman1, M R Cowie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9915735      PMCID： PMC1114725          DOI： 10.1136/bmj.318.7178.238

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  42 in total

1.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.

Authors:  Daniel E Singer; Robert A Hughes; Daryl R Gress; Mary A Sheehan; Lynn B Oertel; Sue Ward Maraventano; Dyan Ryan Blewett; Bernard Rosner; J Philip Kistler
Journal:  N Engl J Med       Date:  1990-11-29       Impact factor: 91.245

2.  "Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients.

Authors:  B LOWN; M G PERLROTH; S KAIDBEY; T ABE; D E HARKEN
Journal:  N Engl J Med       Date:  1963-08-15       Impact factor: 91.245

Review 3.  Hemorrhagic complications of long-term anticoagulant therapy.

Authors:  M N Levine; G Raskob; J Hirsh
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

4.  Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

5.  Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

6.  Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy.

Authors:  R Schmidt; F Fazekas; H Offenbacher; J Dusleag; H Lechner
Journal:  Stroke       Date:  1991-02       Impact factor: 7.914

7.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

8.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors:  M D Ezekowitz; S L Bridgers; K E James; N H Carliner; C L Colling; C C Gornick; H Krause-Steinrauf; J F Kurtzke; S M Nazarian; M J Radford
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

9.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

10.  Stroke Prevention in Atrial Fibrillation Study. Final results.

Authors: 
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690
View more
  4 in total

Review 1.  Case report of paroxysmal atrial fibrillation and anticoagulation.

Authors:  Shmuel Reis; Doron Hermoni; Pnina Livingstone; Jeffrey Borkan
Journal:  BMJ       Date:  2002-11-02

2.  [Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society].

Authors:  U Laufs; U C Hoppe; S Rosenkranz; P Kirchhof; M Böhm; H-C Diener; M Endres; M Grond; W Hacke; T Meinertz; E B Ringelstein; J Röther; M Dichgans
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

Review 3.  Indobufen: an updated review of its use in the management of atherothrombosis.

Authors:  N Bhana; K J McClellan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  [Stroke and atrial fibrillation].

Authors:  G Gahn
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.